Ergün, Y. Et Al. 2022. Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma. Journal of Oncological Science , vol.8, no.2 , 100-106.

Ergün, Y., Uçar, G., Aktürk Esen, S., Bardakçi, M., Kalkan, Z., Urakçi, Z., ... Şeyran, E.(2022). Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma. Journal of Oncological Science , vol.8, no.2, 100-106.

Ergün, Yakup Et Al. "Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma," Journal of Oncological Science , vol.8, no.2, 100-106, 2022

Ergün, Yakup Et Al. "Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma." Journal of Oncological Science , vol.8, no.2, pp.100-106, 2022

Ergün, Y. Et Al. (2022) . "Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma." Journal of Oncological Science , vol.8, no.2, pp.100-106.

@article{article, author={Yakup Ergün Et Al. }, title={Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma}, journal={Journal of Oncological Science}, year=2022, pages={100-106} }